UBC talked with Josh Hardman, founder of Psychedelic Alpha, to discuss the evolving landscape of psychedelic drug development—from shifting regulatory expectations to the role of psychotherapy and the impact of stigma on patient access. Hardman shares a clear-eyed perspective on where the field stands today, the scientific rigor needed to advance it, and what he’s watching most closely as the industry moves toward potential first approvals.
As we look ahead to 2026, patient access and support services face growing complexity—from affordability challenges and evolving care models to the rise of specialty therapies. This blog explores the key trends shaping the healthcare landscape and offers strategic solutions, including AI-powered innovation, digital transformation, and partnerships that drive better outcomes. Discover how UBC is leading the way with patient-first strategies to simplify the patient and product journey.
AI is no longer just a buzzword—it’s a practical tool shaping how we work every day. Learn how UBC leverages AI models to streamline tasks, enhance decision-making, and maintain compliance.
Learn about the FDA's new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC's VP of Data Intelligence and Program Analytics, Jim Shamp.
Discover UBC's insights from the Cell & Gene Meeting on the Mesa, the unique challenges patients face, and the importance of tailored support services to ensure successful treatment journeys
In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.